-
1
-
-
0037117467
-
Identification of persons at high risk for type 2 diabetes mellitus: Do we need the oral glucose tolerance test?
-
Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002;136:575-581
-
(2002)
Ann Intern Med
, vol.136
, pp. 575-581
-
-
Stern, M.P.1
Williams, K.2
Haffner, S.M.3
-
2
-
-
0042168852
-
Detection of undiagnosed diabetes and other hyperglycemia states: The Atherosclerosis Risk in Communities Study
-
Schmidt MI, Duncan BB, Vigo A, Pankow J, Ballantyne CM, Couper D, Brancati F, Folsom AR. Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities Study. Diabetes Care 2003;26:1338-1343
-
(2003)
Diabetes Care
, vol.26
, pp. 1338-1343
-
-
Schmidt, M.I.1
Duncan, B.B.2
Vigo, A.3
Pankow, J.4
Ballantyne, C.M.5
Couper, D.6
Brancati, F.7
Folsom, A.R.8
-
3
-
-
34249654186
-
Prediction of incident diabetes mellitus in middle-aged adults: The Framingham Offspring Study
-
Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 2007;167:1068-1074
-
(2007)
Arch Intern Med
, vol.167
, pp. 1068-1074
-
-
Wilson, P.W.1
Meigs, J.B.2
Sullivan, L.3
Fox, C.S.4
Nathan, D.M.5
D'Agostino Sr., R.B.6
-
4
-
-
30944451953
-
The metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus
-
Wilson PWF, D'Agostino RB Sr , Parise H, Sullivan L, Meigs JB. The metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-3072
-
(2005)
Circulation
, vol.112
, pp. 3066-3072
-
-
Wilson, P.W.F.1
D'Agostino Sr, R.B.2
Parise, H.3
Sullivan, L.4
Meigs, J.B.5
-
5
-
-
33847119543
-
Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: Systematic review and meta-analysis
-
Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007;334:299
-
(2007)
BMJ
, vol.334
, pp. 299
-
-
Gillies, C.L.1
Abrams, K.R.2
Lambert, P.C.3
Cooper, N.J.4
Sutton, A.J.5
Hsu, R.T.6
Khunti, K.7
-
6
-
-
0030038812
-
Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: The Hoorn Study
-
Mooy JM, Gootenhuis PA, Vries Hd, Kostense PJ, Popp-Snijders C, Bouter LM, Heine RJ. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 1996;39:298-305
-
(1996)
Diabetologia
, vol.39
, pp. 298-305
-
-
Mooy, J.M.1
Gootenhuis, P.A.2
Vries, H.3
Kostense, P.J.4
Popp-Snijders, C.5
Bouter, L.M.6
Heine, R.J.7
-
7
-
-
33747739430
-
Body mass index, metabolic syndrome and risk of type 2 diabetes or cardiovascular disease
-
Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan L, D'Agostino RB. Body mass index, metabolic syndrome and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 2906-2912
-
-
Meigs, J.B.1
Wilson, P.W.2
Fox, C.S.3
Vasan, R.S.4
Nathan, D.M.5
Sullivan, L.6
D'Agostino, R.B.7
-
8
-
-
56749101779
-
Genotype score in addition to common risk factors for prediction of type 2 diabetes
-
Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, Manning AK, Florez JC, Wilson PW, D'Agostino RB Sr, Cupples LA. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 2008;359:2208-2219
-
(2008)
N Engl J Med
, vol.359
, pp. 2208-2219
-
-
Meigs, J.B.1
Shrader, P.2
Sullivan, L.M.3
McAteer, J.B.4
Fox, C.S.5
Dupuis, J.6
Manning, A.K.7
Florez, J.C.8
Wilson, P.W.9
D'Agostino Sr, R.B.10
Cupples, L.A.11
-
9
-
-
0024026298
-
Lily lecture 1987: The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM
-
DeFronzo RA. Lily lecture 1987: the triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 1988;37:667-687
-
(1988)
Diabetes
, vol.37
, pp. 667-687
-
-
DeFronzo, R.A.1
-
10
-
-
0037031088
-
Adiponectin and development of type 2 diabetes in the Pima Indian population
-
Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360:57-58
-
(2002)
Lancet
, vol.360
, pp. 57-58
-
-
Lindsay, R.S.1
Funahashi, T.2
Hanson, R.L.3
Matsuzawa, Y.4
Tanaka, S.5
Tataranni, P.A.6
Knowler, W.C.7
Krakoff, J.8
-
11
-
-
0033562455
-
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): A cohort study
-
Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999;353:1649-1652
-
(1999)
Lancet
, vol.353
, pp. 1649-1652
-
-
Schmidt, M.I.1
Duncan, B.B.2
Sharrett, A.R.3
Lindberg, G.4
Savage, P.J.5
Offenbacher, S.6
Azambuja, M.I.7
Tracy, R.P.8
Heiss, G.9
-
12
-
-
2142649221
-
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus
-
Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004;291:1978-1986
-
(2004)
JAMA
, vol.291
, pp. 1978-1986
-
-
Meigs, J.B.1
Hu, F.B.2
Rifai, N.3
Manson, J.E.4
-
13
-
-
1442314640
-
Body iron stores in relation to risk of type 2 diabetes in apparently healthy women
-
Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004;291:711-717
-
(2004)
JAMA
, vol.291
, pp. 711-717
-
-
Jiang, R.1
Manson, J.E.2
Meigs, J.B.3
Ma, J.4
Rifai, N.5
Hu, F.B.6
-
14
-
-
9444244529
-
Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes
-
Nauck MA, Baller B, Meier JJ. Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes. Diabetes 2004;53 (Suppl. 3):S190-S196
-
(2004)
Diabetes
, vol.53
, Issue.SUPPL. 3
-
-
Nauck, M.A.1
Baller, B.2
Meier, J.J.3
-
15
-
-
58149156287
-
-
Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, Loos RJ, Manning AK, Jackson AU, Aulchenko Y, Potter SC, Erdos MR, Sanna S, Hottenga JJ, Wheeler E, Kaakinen M, Lyssenko V, Chen WM, Ahmadi K, Beckmann JS, Bergman RN, Bochud M, Bonnycastle LL, Buchanan TA, Cao A, Cervino A, Coin L, Collins FS, Crisponi L, de Geus EJ, Dehghan A, Deloukas P, Doney AS, Elliott P, Freimer N, Gateva V, Herder C, Hofman A, Hughes TE, Hunt S, Illig T, Inouye M, Isomaa B, Johnson T, Kong A, Krestyaninova M, Kuusisto J, Laakso M, Lim N, Lindblad U, Lindgren CM, McCann OT, Mohlke KL, Morris AD, Naitza S, Orru M, Palmer CN, Pouta A, Randall J, Rathmann W, Saramies J, Scheet P, Scott LJ, Scuteri A, Sharp S, Sijbrands E, Smit JH, Song K, Steinthorsdottir V, Stringham HM, Tuomi T, Tuomilehto J, Uitterlinden AG, Voight BF, Waterworth D, Wichmann HE, Willemsen G, Witteman JC, Yuan X, Zhao JH, Zeggini E, Schlessinger D, Sandhu M, Boomsma DI, Uda M, Spector TD, Penninx BW, Altshuler D, Vollenwe
-
Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, Loos RJ, Manning AK, Jackson AU, Aulchenko Y, Potter SC, Erdos MR, Sanna S, Hottenga JJ, Wheeler E, Kaakinen M, Lyssenko V, Chen WM, Ahmadi K, Beckmann JS, Bergman RN, Bochud M, Bonnycastle LL, Buchanan TA, Cao A, Cervino A, Coin L, Collins FS, Crisponi L, de Geus EJ, Dehghan A, Deloukas P, Doney AS, Elliott P, Freimer N, Gateva V, Herder C, Hofman A, Hughes TE, Hunt S, Illig T, Inouye M, Isomaa B, Johnson T, Kong A, Krestyaninova M, Kuusisto J, Laakso M, Lim N, Lindblad U, Lindgren CM, McCann OT, Mohlke KL, Morris AD, Naitza S, Orru M, Palmer CN, Pouta A, Randall J, Rathmann W, Saramies J, Scheet P, Scott LJ, Scuteri A, Sharp S, Sijbrands E, Smit JH, Song K, Steinthorsdottir V, Stringham HM, Tuomi T, Tuomilehto J, Uitterlinden AG, Voight BF, Waterworth D, Wichmann HE, Willemsen G, Witteman JC, Yuan X, Zhao JH, Zeggini E, Schlessinger D, Sandhu M, Boomsma DI, Uda M, Spector TD, Penninx BW, Altshuler D, Vollenweider P, Jarvelin MR, Lakatta E, Waeber G, Fox CS, Peltonen L, Groop LC, Mooser V, Cupples LA, Thorsteinsdottir U, Boehnke M, Barroso I, Van Duijn C, Dupuis J, Watanabe RM, Stefansson K, McCarthy MI, Wareham NJ, Meigs JB, Abecasis GR. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009;41:77-81
-
-
-
-
16
-
-
58149175143
-
-
Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, Sparso T, Holmkvist J, Marchand M, Delplanque J, Lobbens S, Rocheleau G, Durand E, De Graeve F, Chevre JC, Borch-Johnsen K, Hartikainen AL, Ruokonen A, Tichet J, Marre M, Weill J, Heude B, Tauber M, Lemaire K, Schuit F, Elliott P, Jorgensen T, Charpentier G, Hadjadj S, Cauchi S, Vaxillaire M, Sladek R, Visvikis-Siest S, Balkau B, Levy-Marchal C, Pattou F, Meyre D, Blakemore AI, Jarvelin MR, Walley AJ, Hansen T, Dina C, Pedersen O, Froguel P. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009;41:89-94
-
Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, Sparso T, Holmkvist J, Marchand M, Delplanque J, Lobbens S, Rocheleau G, Durand E, De Graeve F, Chevre JC, Borch-Johnsen K, Hartikainen AL, Ruokonen A, Tichet J, Marre M, Weill J, Heude B, Tauber M, Lemaire K, Schuit F, Elliott P, Jorgensen T, Charpentier G, Hadjadj S, Cauchi S, Vaxillaire M, Sladek R, Visvikis-Siest S, Balkau B, Levy-Marchal C, Pattou F, Meyre D, Blakemore AI, Jarvelin MR, Walley AJ, Hansen T, Dina C, Pedersen O, Froguel P. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009;41:89-94
-
-
-
-
17
-
-
67650070809
-
Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort
-
Kolberg JA, Jørgensen T, Gerwien RW, Hamren S, McKenna MP, Moler E, Rowe MW, Urdea MS, Xu XM, Hansen T, Pedersen O, Borch-Johnsen K. Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care 2009;32:1207-1212
-
(2009)
Diabetes Care
, vol.32
, pp. 1207-1212
-
-
Kolberg, J.A.1
Jørgensen, T.2
Gerwien, R.W.3
Hamren, S.4
McKenna, M.P.5
Moler, E.6
Rowe, M.W.7
Urdea, M.S.8
Xu, X.M.9
Hansen, T.10
Pedersen, O.11
Borch-Johnsen, K.12
-
18
-
-
1442301080
-
Inflammatory markers and risk of developing type 2 diabetes in women
-
Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004;53:693-700
-
(2004)
Diabetes
, vol.53
, pp. 693-700
-
-
Hu, F.B.1
Meigs, J.B.2
Li, T.Y.3
Rifai, N.4
Manson, J.E.5
-
19
-
-
49249138836
-
Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance
-
Hivert MF, Sullivan LM, Fox CS, Nathan DM, D'Agostino RB Sr, Wilson PW, Meigs JB. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 2008;93:3165-3172
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 3165-3172
-
-
Hivert, M.F.1
Sullivan, L.M.2
Fox, C.S.3
Nathan, D.M.4
D'Agostino Sr, R.B.5
Wilson, P.W.6
Meigs, J.B.7
-
20
-
-
33644764947
-
Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: The Framingham Offspring Study
-
Meigs JB, O'Donnell CJ, Tofler GH, Benjamin EJ, Fox CS, Lipinska I, Nathan DM, Sullivan LM, D'Agostino RB, Wilson PW. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 2006;55:530-537
-
(2006)
Diabetes
, vol.55
, pp. 530-537
-
-
Meigs, J.B.1
O'Donnell, C.J.2
Tofler, G.H.3
Benjamin, E.J.4
Fox, C.S.5
Lipinska, I.6
Nathan, D.M.7
Sullivan, L.M.8
D'Agostino, R.B.9
Wilson, P.W.10
-
21
-
-
33644981693
-
Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis
-
Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006;295:1288-1299
-
(2006)
JAMA
, vol.295
, pp. 1288-1299
-
-
Ding, E.L.1
Song, Y.2
Malik, V.S.3
Liu, S.4
-
22
-
-
33847037110
-
Multiple Biomarkers and the Risk of Incident Hypertension
-
Wang TJ, Gona P, Larson MG, Levy D, Benjamin EJ, Tofler GH, Jacques PF, Meigs JB, Rifai N, Selhub J, Robins SJ, Newton-Cheh C, Vasan RS. Multiple Biomarkers and the Risk of Incident Hypertension. Hypertension 2007;49:432-438
-
(2007)
Hypertension
, vol.49
, pp. 432-438
-
-
Wang, T.J.1
Gona, P.2
Larson, M.G.3
Levy, D.4
Benjamin, E.J.5
Tofler, G.H.6
Jacques, P.F.7
Meigs, J.B.8
Rifai, N.9
Selhub, J.10
Robins, S.J.11
Newton-Cheh, C.12
Vasan, R.S.13
-
23
-
-
34548207763
-
Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: The Framingham Offspring Study
-
Ingelsson E, Pencina MJ, Tofler GH, Benjamin EJ, Lanier KJ, Jacques PF, Fox CS, Meigs JB, Levy D, Larson MG, Selhub J, D'Agostino RB Sr, Wang TJ, Vasan RS. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation 2007;116:984-992
-
(2007)
Circulation
, vol.116
, pp. 984-992
-
-
Ingelsson, E.1
Pencina, M.J.2
Tofler, G.H.3
Benjamin, E.J.4
Lanier, K.J.5
Jacques, P.F.6
Fox, C.S.7
Meigs, J.B.8
Levy, D.9
Larson, M.G.10
Selhub, J.11
D'Agostino Sr, R.B.12
Wang, T.J.13
Vasan, R.S.14
-
24
-
-
33845709506
-
Multiple biomarkers for the prediction of first major cardiovascular events and death
-
Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006;355:2631-2639
-
(2006)
N Engl J Med
, vol.355
, pp. 2631-2639
-
-
Wang, T.J.1
Gona, P.2
Larson, M.G.3
Tofler, G.H.4
Levy, D.5
Newton-Cheh, C.6
Jacques, P.F.7
Rifai, N.8
Selhub, J.9
Robins, S.J.10
Benjamin, E.J.11
D'Agostino, R.B.12
Vasan, R.S.13
-
25
-
-
43549117072
-
Use of multiple biomarkers to improve the prediction of death from cardiovascular causes
-
Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlov J. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008;358:2107-2116
-
(2008)
N Engl J Med
, vol.358
, pp. 2107-2116
-
-
Zethelius, B.1
Berglund, L.2
Sundstrom, J.3
Ingelsson, E.4
Basu, S.5
Larsson, A.6
Venge, P.7
Arnlov, J.8
|